Akebia Therapeutics, Inc. (AKBA)
NASDAQ·Healthcare·Biotechnology
$0.93
+3.69%
Mkt Cap $250.90M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (3 analysts)
$4.00
Range $4.00 – $4.00
Implied Upside
+328.9%
Consensus $4.00 vs current $0.93
NASDAQ·Healthcare·Biotechnology
$0.93
+3.69%
Mkt Cap $250.90M
Buy
4
Hold
0
Sell
0
Price Target (3 analysts)
$4.00
Range $4.00 – $4.00
+328.9%
Consensus $4.00 vs current $0.93